Literature DB >> 16293964

Pseudocyst treatment in chronic pancreatitis--surgical treatment of the underlying disease increases the long-term success.

Wolfgang Schlosser1, Marco Siech, Hans G Beger.   

Abstract

BACKGROUND: For reasons of persisting controversies concerning indications for surgery, we evaluated chronic pancreatitis patients following pancreatic head resection or drainage procedure for pseudocysts located in the pancreatic head.
MATERIAL AND METHODS: 206 patients (166 male, 40 female) with chronic pancreatitis and pseudocysts in the pancreatic head were operated between April 1982 and July 2001. 169 patients (82%) were treated with the duodenum-preserving pancreatic head resection, a pseudocyst-jejunostomy was performed in 37 patients (18%).
RESULTS: The hospital mortality was 0.4%. The late mortality was 19% in a median follow-up of 7.3 years. The rate of patients with complete relief of pain was significantly higher after resection compared to drainage procedure in the long-term follow-up (94 vs. 75%; p = 0.003). With regard to recurrence of pseudocysts, patients had an elevated rate of reoperations following drainage procedure (13 vs. 1%; p = 0.008). The endocrine function was significantly better preserved in patients of the drainage group compared to the resection group (no diabetes 67 vs. 35%, p < 0.01).
CONCLUSION: The resection has, compared to drainage procedures alone, the advantage of low recurrence rate of pseudocysts and a high rate of pain-free patients in the long-term follow-up. However, the risk of diabetes is increased in the resection group. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 16293964     DOI: 10.1159/000089769

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  1 in total

1.  Evidence-based clinical practice guidelines for chronic pancreatitis 2015.

Authors:  Tetsuhide Ito; Hiroshi Ishiguro; Hirotaka Ohara; Terumi Kamisawa; Junichi Sakagami; Naohiro Sata; Yoshifumi Takeyama; Morihisa Hirota; Hiroyuki Miyakawa; Hisato Igarashi; Lingaku Lee; Takashi Fujiyama; Masayuki Hijioka; Keijiro Ueda; Yuichi Tachibana; Yoshio Sogame; Hiroaki Yasuda; Ryusuke Kato; Keisho Kataoka; Keiko Shiratori; Masanori Sugiyama; Kazuichi Okazaki; Shigeyuki Kawa; Yusuke Tando; Yoshikazu Kinoshita; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-01-04       Impact factor: 7.527

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.